Company / SG&A per Share
Pfizer SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.42
FY2025
5-year range
$2.06 / $2.57
FY2021-FY2025
Trend
-6.0%
vs FY2024
Sector context
#74 of 210
Health Care
What the data says
At $2.42, Pfizer's sg&a per share ranks #137 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $1.94 in FY2020 to $2.57 in FY2024.
Based on SEC 10-K filings.
2.42 in FY2025 with a 5-year CAGR of +4.5%.
Increased from $2.23 to $2.42 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +5.5%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
#137 of 210 in Health CareTop 65% of 210This company $2.42 Sector average $40.75
▼
-94.1% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 6.0% year-over-year.
- Ranks #74 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.42 | -6.0% |
| FY2024 | $2.57 | +15.5% |
| FY2023 | $2.23 | +8.1% |
| FY2022 | $2.06 | -8.2% |
| FY2021 | $2.24 | +15.6% |
| FY2020 | $1.94 | -7.6% |
| FY2019 | $2.10 | -12.8% |
| FY2018 | $2.41 | +1.8% |
| FY2017 | $2.37 | +7.9% |
| FY2016 | $2.19 | +2.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026